Claims from 192,793 newly diagnosed dry eye disease patients showed prescription initiation in 12.4%, indicating substantial ...
Mortality rates for DTR Gram-negative infections remain unchanged despite the increased availability and use of newer antimicrobial agents.
Those residing in low food access areas have higher comorbidity score and more complications, higher incidence of reoperation.
A 1000 mg ×2 induction regimen followed by maintenance every 6–12 months was associated with near-elimination of relapse ...
The EndoArt artificial endothelial layer showed positive results across multiple studies presented by specialists at the ...
Q4 2025 Earnings Call April 15, 2026 5:00 PM EDTCompany ParticipantsBradford Amman - CFO, Treasurer & SecretaryR.
With new data and treatment strategies discussed at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual ...
Shayla Talei, 31, documents her life with multiple debilitating chronic illness for over 249,000 followers on TikTok ...
Parents of kids with neurodevelopmental disorders may be at increased risk of cardiovascular disease, a national cohort study ...
The FDA has granted Fast Track designation to KT-621, a first-in-class oral STAT6 degrader for moderate to severe eosinophilic asthma.
Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva,” the “Company” “we” or “us”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results